✦ LIBER ✦

Effect of adding sitagliptin, a dipeptidyl peptidase-4 inhibitor, to metformin on 24-h glycaemic control and β-cell function in patients with type 2 diabetes

✍ Scribed by R. Brazg; L. Xu; C. Dalla Man; C. Cobelli; K. Thomas; P. P. Stein

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of sitagliptin, a dipeptidyl pept

✍ L. Xu; C. Dalla Man; B. Charbonnel; G. Meninger; M. J. Davies; D. Williams-Herma 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB

Effect of initial combination therapy wi

✍ D. Williams-Herman; L. Xu; R. Teng; G. T. Golm; J. Johnson; M. J. Davies; K. D. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 794 KB

Efficacy and safety of the dipeptidyl pe

✍ K. Hermansen; M. Kipnes; E. Luo; D. Fanurik; H. Khatami; P. Stein; Sitagliptin S 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB

Efficacy and safety of the dipeptidyl pe

✍ M. A. Nauck; G. Meininger; D. Sheng; L. Terranella; P. P. Stein; Sitagliptin Stu 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 191 KB

Effect of linagliptin monotherapy on gly

✍ S. Del Prato; A. H. Barnett; H. Huisman; D. Neubacher; H.-J. Woerle; K. A. Dugi 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 685 KB